Published in J Med Microbiol on September 01, 2005
Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol (2011) 3.81
Clostridium difficile infection. Am J Med Sci (2010) 1.17
Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection. Therap Adv Gastroenterol (2011) 1.05
Faecal microbiota transplantation: applications and limitations in treating gastrointestinal disorders. BMJ Open Gastroenterol (2016) 1.02
Recurrent Clostridium difficile infection: From colonization to cure. Anaerobe (2015) 1.00
Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cells. Gut Pathog (2009) 0.99
New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin Infect Dis (2015) 0.97
Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am (2009) 0.93
Safety and immunomodulatory effects of three probiotic strains isolated from the feces of breast-fed infants in healthy adults: SETOPROB study. PLoS One (2013) 0.91
Probiotics in clostridium difficile Infection. J Clin Gastroenterol (2011) 0.86
Treatment Strategies for Recurrent Clostridium difficile Infection. Can J Hosp Pharm (2013) 0.82
Future novel therapeutic agents for Clostridium difficile infection. Expert Opin Investig Drugs (2010) 0.82
In Vitro Evaluation of Antimicrobial Activity of Lactic Acid Bacteria against Clostridium difficile. Toxicol Res (2013) 0.82
Probiotics, prebiotics and the gastrointestinal tract in health and disease. Inflammopharmacology (2014) 0.81
Clinical update for the diagnosis and treatment of Clostridium difficile infection. World J Gastrointest Pharmacol Ther (2014) 0.81
Gleaning Insights from Fecal Microbiota Transplantation and Probiotic Studies for the Rational Design of Combination Microbial Therapies. Clin Microbiol Rev (2017) 0.78
Probiotics for the Primary and Secondary Prevention of C. difficile Infections: A Meta-analysis and Systematic Review. Antibiotics (Basel) (2015) 0.77
Trends in Clostridium difficile Disease: Epidemiology and Intervention. Infect Med (2009) 0.75
Examination of bacterial inhibition using a catalytic DNA. PLoS One (2014) 0.75
Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med (2004) 6.77
A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology (2013) 4.06
Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology (2011) 3.84
Risks and benefits of infliximab for the treatment of Crohn's disease. Clin Gastroenterol Hepatol (2006) 2.88
Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor. Lancet (2002) 2.74
Computed tomography characteristics of Burkholderia pseudomallei liver abscess. Clin Infect Dis (2006) 2.64
Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature. Clin Infect Dis (2002) 2.09
LRRK2 is involved in the IFN-gamma response and host response to pathogens. J Immunol (2010) 1.85
To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. Clin Infect Dis (2002) 1.76
Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One (2012) 1.66
Dysregulation of Reg gene expression occurs early in gastrointestinal tumorigenesis and regulates anti-apoptotic genes. Cancer Biol Ther (2006) 1.63
Clostridium difficile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect Control Hosp Epidemiol (2007) 1.61
Atypical avian influenza (H5N1). Emerg Infect Dis (2004) 1.60
Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. J Med Microbiol (2009) 1.58
Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin Infect Dis (2004) 1.26
Transition of adolescents with inflammatory bowel disease from pediatric to adult care: a survey of adult gastroenterologists. J Pediatr Gastroenterol Nutr (2009) 1.22
The emergence of a novel ceftazidime-resistant CTX-M extended-spectrum beta-lactamase, CTX-M-55, in both community-onset and hospital-acquired infections in Thailand. Diagn Microbiol Infect Dis (2007) 1.18
Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ (2013) 1.18
Long-term outcomes of HIV-infected patients with <95% rates of adherence to nonnucleoside reverse-transcriptase inhibitors. Clin Infect Dis (2010) 1.12
Emergence of New Delhi metallo-β-lactamase type 1-producing enterobacteriaceae and non-enterobacteriaceae: global case detection and bacterial surveillance. Int J Infect Dis (2013) 1.11
Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr (2002) 1.11
The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infect Dis (2012) 1.10
Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control (2007) 1.07
Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases. Am J Gastroenterol (2013) 1.05
Evaluation of Ochrobactrum intermedium bacteremia in a patient with bladder cancer. Diagn Microbiol Infect Dis (2005) 1.04
Surveillance for vancomycin-resistant enterococci: type, rates, costs, and implications. Infect Control Hosp Epidemiol (2006) 1.03
Precise dissection of an Escherichia coli O157:H7 outbreak by single nucleotide polymorphism analysis. J Clin Microbiol (2013) 1.00
Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort. Inflamm Bowel Dis (2015) 0.99
Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease. Gut (2011) 0.97
Chemical and cytokine features of innate immunity characterize serum and tissue profiles in inflammatory bowel disease. Proc Natl Acad Sci U S A (2013) 0.97
Analysis of treatment effects on the microbial ecology of the human intestine. FEMS Microbiol Ecol (2006) 0.96
Inflammatory bowel disease and environmental influences. Gastroenterol Clin North Am (2002) 0.95
The impact of primary prophylaxis for cryptococcosis on fluconazole resistance in Candida species. J Acquir Immune Defic Syndr (2008) 0.94
Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Control Hosp Epidemiol (2008) 0.94
Dual infection with Mycobacterium tuberculosis and Pneumocystis jiroveci Lymphadenitis in a Patient with HIV infection: case report and review of the literature. AIDS Patient Care STDS (2006) 0.94
Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. Inflamm Bowel Dis (2013) 0.93
Etiology of community-acquired pneumonia. Clin Chest Med (2005) 0.92
Marijuana use patterns among patients with inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.92
Nonjudicious dispensing of antibiotics by drug stores in Pratumthani, Thailand. Infect Control Hosp Epidemiol (2008) 0.92
Efficacy and safety of natalizumab in Crohn's disease patients treated at 6 Boston academic hospitals. Inflamm Bowel Dis (2013) 0.92
Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. Inflamm Bowel Dis (2010) 0.92
Mortality associated with Pandrug-resistant Acinetobacter baumannii infections in Thailand. Am J Infect Control (2009) 0.92
A nationally coordinated laboratory system for human avian influenza A (H5N1) in Thailand: program design, analysis, and evaluation. Clin Infect Dis (2008) 0.91
Development of Stage of Readiness and decisional balance instruments: tools to enhance clinical decision-making for adherence to antiretroviral therapy. AIDS Behav (2006) 0.90
Echovirus type 11: outbreak of hand-foot-and-mouth disease in a Thai hospital nursery. Clin Infect Dis (2005) 0.90
Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Inflamm Bowel Dis (2011) 0.89
Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review. Pharmacotherapy (2002) 0.88
Systematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection. Antimicrob Agents Chemother (2013) 0.87
Influenza outbreak among health care workers in an avian influenza (H5N1)-endemic setting. Clin Infect Dis (2006) 0.87
Outbreak of varicella-zoster virus infection among Thai healthcare workers. Infect Control Hosp Epidemiol (2007) 0.87
Outbreaks of influenza A among nonvaccinated healthcare workers: implications for resource-limited settings. Infect Control Hosp Epidemiol (2008) 0.86
Growth factors as treatment options for intestinal inflammation. Ann N Y Acad Sci (2006) 0.86
Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci (2011) 0.86
Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes. Infect Control Hosp Epidemiol (2008) 0.85
Barriers to enrollment in inflammatory bowel disease randomized controlled trials: an investigation of patient perspectives. Inflamm Bowel Dis (2012) 0.85
Assessment of knowledge, attitudes, and practices regarding isolation precautions among Iranian healthcare workers. Infect Control Hosp Epidemiol (2005) 0.85
Free tissue transfer to a difficult wound of the lower extremity. Ann Plast Surg (2004) 0.85
Validation of interactive voice response system administration of the Short Inflammatory Bowel Disease Questionnaire. Inflamm Bowel Dis (2009) 0.85
A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price? Infect Control Hosp Epidemiol (2004) 0.84
Tuberculin skin tests among medical students with prior bacille-Calmette Guérin vaccination in a setting with a high prevalence of tuberculosis. Infect Control Hosp Epidemiol (2009) 0.84
Effectiveness of environmental and infection control programs to reduce transmission of Clostridium difficile. Clin Infect Dis (2004) 0.83
Treatment of cryptococcosis in the setting of HIV coinfection. Expert Rev Anti Infect Ther (2007) 0.83
Practices to prevent multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus in Thailand: a national survey. Am J Infect Control (2012) 0.83
Severe Clostridium difficile colitis: the role of intracolonic vancomycin? Am J Med (2002) 0.83
Antiretroviral drug resistance among antiretroviral-naive individuals with HIV infection of unknown duration in Thailand. Clin Infect Dis (2008) 0.82
Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis (2015) 0.82
Immediate versus tailored prophylaxis to prevent symptomatic recurrences after surgery for ileocecal Crohn's disease? Surgery (2011) 0.81
Fever of unknown origin in patients with HIV infection in Thailand: an observational study and review of the literature. Int J STD AIDS (2008) 0.81
Impact of education and an antifungal stewardship program for candidiasis at a Thai tertiary care center. Infect Control Hosp Epidemiol (2010) 0.81
Comparison of methods of measuring pharmacy sales of antibiotics without prescriptions in Pratumthani, Thailand. Infect Control Hosp Epidemiol (2009) 0.81
Computed tomography characteristics of hepatic and splenic abscesses associated with melioidosis: a 7-year study. J Med Imaging Radiat Oncol (2011) 0.81
Reduction of seasonal influenza transmission among healthcare workers in an intensive care unit: a 4-year intervention study in Thailand. Infect Control Hosp Epidemiol (2010) 0.81
Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol (2011) 0.81
Increase in chlorhexidine minimal inhibitory concentration of Acinetobacter baumannii clinical isolates after implementation of advanced source control. Infect Control Hosp Epidemiol (2014) 0.81
Correlation of antibiotic use and antimicrobial resistance in Pratumthani, Thailand, 2000 to 2006. Am J Infect Control (2008) 0.80
Four Thai patients with chronic diarrhea, malabsorption, and weight loss. Diagnosis: Capillariasis associated with tubular narrowing of multiple small-bowel loops with fold effacement. Clin Infect Dis (2013) 0.80
Treatment of select open calcaneus fractures with reduction and internal fixation: an intermediate-term review. Foot Ankle Int (2008) 0.80
Photo quiz. A Thai woman with fever and skin lesions. Clin Infect Dis (2005) 0.80
Rapid testing for pandemic influenza A (H1N1): diagnostic test utility and specimen source. Infect Control Hosp Epidemiol (2010) 0.80
Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease. Clin Gastroenterol Hepatol (2006) 0.80
Reconstruction of through-and-through gunshot wounds to the feet with free gracilis muscle flaps. Ann Plast Surg (2003) 0.79
Clostridium difficile-associated disease treatment response depends on definition of cure. Clin Infect Dis (2007) 0.79
Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae in Thailand. Infect Control Hosp Epidemiol (2007) 0.79
Open fractures of the calcaneus: soft-tissue injury determines outcome. J Bone Joint Surg Am (2004) 0.79
Bioterrorism risk perceptions and educational needs of public health professionals before and after September 11, 2001: a national needs assessment survey. J Public Health Manag Pract (2004) 0.79
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin. Int J Antimicrob Agents (2012) 0.79
Application of a 3-item adherence metric to monitor antiretroviral medication adherence in a resource-limited setting. J Acquir Immune Defic Syndr (2010) 0.79
Importance of routine public health influenza surveillance: detection of an unusual W-shaped influenza morbidity curve. Am J Epidemiol (2009) 0.78
Risk factors and outcomes of Candida albicans and non-albicans Candida species at a Thai tertiary care center. Am J Infect Control (2009) 0.78
Predictors of mortality among patients with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand . Infect Control Hosp Epidemiol (2008) 0.78
Evidence of vaccine protection among thai medical students and implications for occupational health. Infect Control Hosp Epidemiol (2009) 0.78
Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings? Expert Rev Anti Infect Ther (2013) 0.78
Infection prevention control bundle of multidrug-resistant Acinetobacter baumannii and methicillin-resistant Staphylococcus aureus: which one is more important? Infect Control Hosp Epidemiol (2014) 0.78
Salmonella group C necrotizing fasciitis: a case report and review of the literature. Diagn Microbiol Infect Dis (2006) 0.78
Implementation of an infection control bundle in a school to reduce transmission of influenza-like illness during the novel influenza A 2009 H1N1 pandemic. Infect Control Hosp Epidemiol (2010) 0.78
Serum sickness-like reaction associated with inactivated influenza vaccination among Thai health care personnel: risk factors and outcomes. Clin Infect Dis (2009) 0.78
Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database. Inflamm Bowel Dis (2017) 0.77
Computed tomography characteristics of Burkholderia pseudomallei-associated liver abscess. Clin Infect Dis (2006) 0.77
Black-water floods and hospital-based postflood mold investigations. Infect Control Hosp Epidemiol (2012) 0.77